Animace načítání

Stránka se připravuje...


Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

XXŘ&Xxxxxx;XXX&Xxxxxx; KOMISE (EU) č. 618/2012

xx dne 10. čxxxxxxx 2012,

xxxx&xxxxxx;x xx xxx účely xřxxxůxxxxx&xxxxxx; vědecko-technickému xxxxxxx xěx&xxxxxx; xxř&xxxxxx;xxx&xxxxxx; Xxxxxxx&xxxxxx;xx xxxxxxxxxx a Xxxx (XX) č. 1272/2008 x xxxxxxxxxxx, xxxxčxx&xxxxxx;x&xxxxxx; x xxxxx&xxxxxx; látek x xxěx&xxxxxx;

(Xxxx x x&xxxxxx;xxxxxx pro XXX)

EVROPSKÁ XXXXXX,

x&xxxx;xxxxxxx na Smlouvu x&xxxx;xxxxxx&xxxxxx;x&xxxxxx; Xxxxxxx&xxxxxx; unie,

s ohledem xx nařízení Xxxxxxx&xxxxxx;xx xxxxxxxxxx x&xxxx;Xxxx (XX) č.&xxxx;1272/2008 xx xxx 16.&xxxx;xxxxxxxx 2008 x&xxxx;xxxxxxxxxxx, xxxxčxx&xxxxxx;x&xxxxxx; a balení x&xxxxxx;xxx x&xxxx;xxěx&xxxxxx;, x&xxxx;xxěxě a zrušení xxěxxxx 67/548/XXX x&xxxx;1999/45/XX x&xxxx;x&xxxx;xxěxě xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1907/2006 (1), x&xxxx;xxxx&xxxxxx;xx na čx.&xxxx;37 xxxx. 5 xxxxxx&xxxxxx;xx nařízení,

xxxxxxxx k těmto xůxxxůx:

(1)

Č&xxxxxx;xx 3 přílohy XX nařízení (XX) č.&xxxx;1272/2008 xxxxxxxx xxx xxxxxxx xxxxxxxxxxxx&xxxxxx;xx xxxxxxxxxx&xxxxxx; x&xxxx;xxxxčxx&xxxxxx; xxxxxxxčx&xxxxxx;xx x&xxxxxx;xxx. X&xxxx;xxxxxxx 3.1 je xxxxxx xxxxxx xxxxxxxxxxxx&xxxxxx;xx xxxxxxxxxx&xxxxxx; x&xxxx;xxxxčxx&xxxxxx; nebezpečných x&xxxxxx;xxx xx základě xxxx&xxxxxx;xx&xxxxxx; xxxxxxxx&xxxxxx;xx x&xxxx;č&xxxxxx;xxxxx 2 až 5 xř&xxxxxx;xxxx X&xxxx;xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1272/2008. V tabulce 3.2 xx uveden xxxxxx xxxxxxxxxxxx&xxxxxx;xx xxxxxxxxxx&xxxxxx; a xxxxčxx&xxxxxx; nebezpečných x&xxxxxx;xxx xx x&xxxxxx;xxxxě kritérií xxxxxxxx&xxxxxx;xx v příloze XX xxěxxxxx Xxxx 67/548/XXX xx xxx 27. června 1967 x xxxxžxx&xxxxxx;x&xxxxxx; xx&xxxxxx;xx&xxxxxx;xx x xxx&xxxxxx;xx&xxxxxx;xx xřxxxxxů týkajících xx xxxxxxxxxxx, xxxxx&xxxxxx; a xxxxčxx&xxxxxx;x&xxxxxx; xxxxxxxčx&xxxxxx;xx látek (2). Xxxx xxx seznamy xx xxxx&xxxxxx; xxěxxx, xxx xx xxxx xxxx zahrnuty xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx x&xxxxxx;xxx, na xxxx&xxxxxx; xx xxž xxxxxxxx xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx, x xxx xxxxxxxxxx x xxx&xxxxxx; xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx.

(2)

X&xxxxxx;xxx xxx xxxxxxx&xxxxxx;x&xxxxxx; xxxxx Xxxxxxx&xxxxxx; xxxxxxxx xxx chemické x&xxxxxx;xxx (XXXX) xxxxx xxxxxxxxxx x x&xxxxxx;xxxůx harmonizované xxxxxxxxxxx a xxxxčxx&xxxxxx;x&xxxxxx; x&xxxxxx;xxx, xxxx&xxxxxx; byly xřxxxxžxxx xxxxxxřx x xxxxxxx x čx&xxxxxx;xxxx 37 nařízení (XX) č. 1272/2008. Na x&xxxxxx;xxxxě xěxxxx stanovisek x na základě xřxxxx&xxxxxx;xxx xxxxžxx&xxxxxx;xx od xxxčxx&xxxxxx;xx xxxxx xx xřxxx xxěxxx přílohu XX xxř&xxxxxx;xxx&xxxxxx; (ES) č. 1272/2008, xxx xxxx xxxxžxxx harmonizace xxxxxxxxxxx a xxxxčxx&xxxxxx;x&xxxxxx; xěxxxx&xxxxxx;xx x&xxxxxx;xxx.

(3)

Xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx xxxxxxxx&xxxxxx; x&xxxx;č&xxxxxx;xxx 3 xř&xxxxxx;xxxx VI xxř&xxxxxx;xxx&xxxxxx; (XX) č. 1272/2008, xx xxěx&xxxxxx; xxxxxx xxř&xxxxxx;xxx&xxxxxx;, xx xx xxxěxx xxxž&xxxxxx;x xxxxxxxxřxxxě, xxxxť xxxxxx&xxxxxx;řxx&xxxxxx; xxxxxxxx xxxxx xxxřxxxxxx xxčxx&xxxxxx; xxxxx&xxxxxx; xx to, aby xxxxx xxx&xxxxxx;x xxxxxxxxxx&xxxxxx;x xřxxxůxxxxx xxxxčxx&xxxxxx;x&xxxxxx; x&xxxx;xxxxx&xxxxxx; x&xxxxxx;xxx x&xxxx;xxěx&xxxxxx; x xxxxxx xxxxxxx&xxxxxx;x&xxxxxx; x&xxxxxx;xxxx. Xxxxxx&xxxxxx;řxx&xxxxxx; xxxxxxxx xxxxx xxxxě xxxx potřebovat xxčxx&xxxxxx; časové xxxxx&xxxxxx; xx xx, aby xxxxx xxxxxx xxxxxxxxxx xxx registraci, xxxx&xxxxxx; xxxx&xxxxxx;xxx&xxxxxx; x&xxxx;xxx&xxxxxx;xx harmonizovaných xxxxxxxxxx&xxxxxx; x&xxxxxx;xxx xxxxxxxxxxxx&xxxxxx;xx xxxx xxxxxxxxxxx&xxxxxx;, xxxxxxxx&xxxxxx; xxxx xxxxxx&xxxxxx; pro xxxxxxxxxx, xxxxxxxx&xxxxxx; 1A x&xxxx;1X (tabulka 3.1) x&xxxx;xxxxxxxx&xxxxxx; 1 x&xxxx;2 (xxxxxxx 3.2) xxxx xxxx xxxxxx xxxxxx&xxxxxx; xxx xxxx&xxxxxx; organismy x&xxxx;xxžxxxx&xxxxxx; vyvolat dlouhodobé xxxř&xxxxxx;xxxx&xxxxxx; &xxxxxx;čxxxx xx xxxx&xxxxxx;x xxxxxřxx&xxxxxx;, zejména xxx povinnosti xxxxxxxx&xxxxxx; x&xxxx;čx&xxxxxx;xxx&xxxx;23 nařízení Xxxxxxx&xxxxxx;xx xxxxxxxxxx a Rady (XX) č.&xxxx;1907/2006 xx xxx 18.&xxxx;xxxxxxxx 2006 x&xxxx;xxxxxxxxxx, xxxxxxxx&xxxxxx;, povolování x&xxxx;xxxxxx&xxxxxx;x&xxxxxx; xxxxxxx&xxxxxx;xx látek, x&xxxx;xř&xxxxxx;xxx&xxxxxx; Xxxxxxx&xxxxxx; xxxxxxxx pro xxxxxxx&xxxxxx; látky, x&xxxx;xxěxě xxěxxxxx 1999/45/XX a o zrušení xxř&xxxxxx;xxx&xxxxxx; Xxxx (XXX) č.&xxxx;793/93, xxř&xxxxxx;xxx&xxxxxx; Xxxxxx (XX) č.&xxxx;1488/94, xxěxxxxx Xxxx 76/769/EHS a směrnic Xxxxxx 91/155/XXX, 93/67/EHS, 93/105/XX a 2000/21/ES (3).

(4)

X&xxxx;xxxxxxx x&xxxx;xřxxxxxx&xxxxxx;x xxxxxxxxx&xxxxxx;x xxř&xxxxxx;xxx&xxxxxx; (XX) č. 1272/2008, xxxx&xxxxxx; xxxžňxxx xžxx&xxxxxx; nových xxxxxxxxx&xxxxxx; s předstihem xx x&xxxxxx;xx xxxxxxxxxxxxx, by xěxx x&xxxxxx;x dodavatelé xxžxxxx xxxž&xxxxxx;xxx xxxxxxxxxxxxxx xxxxxxxxxxx xxxxxxxxxx v části 3 xř&xxxxxx;xxxx XX xxř&xxxxxx;xxx&xxxxxx; (ES) č. 1272/2008, xx xxěx&xxxxxx; xxxxxx xxř&xxxxxx;xxx&xxxxxx;, a xřxxxůxxxxx xxxxčxx&xxxxxx;x&xxxxxx; x xxxxx&xxxxxx; xxxxx&xxxxxx;xxx&xxxxxx;x&xxxxxx;x xxůxxxxx xx xxxxxxxxx&xxxxxx; x&xxxxxx;xx xřxx 1. prosincem 2013.

(5)

Xxxxřxx&xxxxxx; xxxxxxxx&xxxxxx; x&xxxxxx;xxx xxř&xxxxxx;xxx&xxxxxx;x jsou x&xxxx;xxxxxxx xx xxxxxxxxxxx výboru xř&xxxxxx;xxx&xxxxxx;xx xxxxx čx&xxxxxx;xxx 133 xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1907/2006,

XŘXXXXX XXXX XXŘ&Xxxxxx;XXX&Xxxxxx;:

Čx&xxxxxx;xxx&xxxx;1

Č&xxxxxx;xx 3 xř&xxxxxx;xxxx XX xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1272/2008 xx xěx&xxxxxx; xxxxx:

1)

Xxxxxxx 3.1 xx xěx&xxxxxx; xxxxx:

a)

záznamy, xxxx&xxxxxx; xxxxx&xxxxxx;xxx&xxxxxx; záznamům xxxxxx&xxxxxx;x x xř&xxxxxx;xxxx X, xx xxxxxxxx&xxxxxx; x&xxxxxx;xxxxx xxxxxxxx&xxxxxx;xx v uvedené xř&xxxxxx;xxxx;

x)

x&xxxxxx;xxxxx xxxxxx&xxxxxx; x xř&xxxxxx;xxxx XX xx xxx&xxxxxx;xxx&xxxxxx; x xxxxxxx x xxxxxxxxxxx&xxxxxx; záznamů xxxxxxxx&xxxxxx;xx x&xxxx;xxxxxxx 3.1

2)

Xxxxxxx 3.2 xx mění xxxxx:

x)

x&xxxxxx;xxxxx, xxxx&xxxxxx; xxxxx&xxxxxx;xxx&xxxxxx; x&xxxxxx;xxxxůx xxxxxx&xxxxxx;x x příloze XXX, xx xxxxxxxx&xxxxxx; x&xxxxxx;xxxxx stanovenými x&xxxx;xxxxxx&xxxxxx; xř&xxxxxx;xxxx;

x)

x&xxxxxx;xxxxx uvedené x xř&xxxxxx;xxxx XX se xxx&xxxxxx;xxx&xxxxxx; x xxxxxxx x xxxxxxxxxxx&xxxxxx; záznamů xxxxxxxx&xxxxxx;xx v tabulce 3.2

Čx&xxxxxx;xxx&xxxx;2

Xxxx xxř&xxxxxx;xxx&xxxxxx; vstupuje x&xxxx;xxxxxxxx xxxx&xxxxxx;x&xxxxxx;x xxxx xx xxxx&xxxxxx;&xxxxxx;xx&xxxxxx; x&xxxx;&Xxxxxx;řxxx&xxxxxx;x xěxxx&xxxxxx;xx Xxxxxxx&xxxxxx; unie.

Čx&xxxxxx;xxx 1 xx xxxžxxx xxx xxx 1. xxxxxxxx 2013.

Xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx xxxxxxxx&xxxxxx; x&xxxx;č&xxxxxx;xxx 3 xř&xxxxxx;xxxx VI xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1272/2008, ve xxěx&xxxxxx; xxxxxx nařízení, xxx použít xřxx 1.&xxxx;xxxxxxxxx 2013.

Xxxx xxř&xxxxxx;xxx&xxxxxx; je x&xxxxxx;xxxx&xxxxxx; v celém rozsahu x&xxxx;xř&xxxxxx;xx použitelné xx x&xxxxxx;xxx čxxxxx&xxxxxx;xx xx&xxxxxx;xxxx.

X Xxxxxxx xxx 10. čxxxxxxx 2012.

Xx Xxxxxx

Xxx&xxxxxx; Xxxxxx BARROSO

předseda

(1)&xxxx;&xxxx;&Xxxxxx;ř.&xxxx;xěxx.&xxxx;X&xxxx;353, 31.12.2008, s. 1.

(2)&xxxx;&xxxx;&Xxxxxx;ř. xěxx. 196, 16.8.1967, x. 1.

(3)&xxxx;&xxxx;&Xxxxxx;ř.&xxxx;xěxx.&xxxx;X&xxxx;136, 29.5.2007, x.&xxxx;3.

XŘ&Xxxxxx;XXXX&xxxx;X

Xxxxxxx&xxxxxx; č&xxxxxx;xxx

Xxxxx&xxxxxx;xxxx&xxxxxx; xxxxxxxxxxxx xxxxxxx&xxxxxx;xx látek

Číslo XX

Č&xxxxxx;xxx XXX

Xxxxxxxxxxx

Xxxxčxx&xxxxxx;

Xxxxxxxxx&xxxxxx; xxxxxxx. limity, xxxxxxxxxxčx&xxxxxx; faktory

Xxxx.

Kódy xř&xxxxxx;x x kategorií nebezpečnosti

Kódy xxxxxxxxx&xxxxxx;xx xěx x xxxxxxxčxxxxx

X&xxxxxx;xx x&xxxxxx;xxxxžx&xxxxxx;xx symbolů x signálních xxxx

X&xxxxxx;xx xxxxxxxxx&xxxxxx;xx vět x xxxxxxxčxxxxx

X&xxxxxx;xx doplň. standardních xěx x xxxxxxxčxxxxx

„009-016-00-2

xxxxxxxxx xxxxxxxxxxxxxxxxxxx [1]

237-410-6 [1]

13775-53-6 [1]

XXXX RE 1

Xxxxx Xxx. 4

Aquatic Xxxxxxx 2

X372

X332

X411

XXX07

XXX08

XXX09

Xxx

X372

X332

X411

&xxxx;

&xxxx;

&xxxx;

xxxxxxxxx hexafluoroaluminate (xxxxxxxx) [2]

239-148-8 [2]

15096-52-3 [2]

603-012-00-X

2-xxxxxxxxxxxxx;

xxxxxxxx xxxxxx xxxxxxxxx xxxxx

203-804-1

110-80-5

Xxxx. Xxx. 3

Repr. 1X

Acute Xxx. 3

Xxxxx Xxx. 4

X226

X360XX

X331

X302

XXX02

XXX08

XXX06

Xxx

X226

X360XX

X331

X302

&xxxx;

&xxxx;

&xxxx;

603-025-00-0

xxxxxxxxxxxxxxx

203-726-8

109-99-9

Xxxx. Xxx. 2

Xxxx. 2

Xxx Xxxxx. 2

STOT XX 3

H225

H351

X319

H335

GHS02

XXX07

XXX08

Xxx

X225

X351

H319

H335

XXX019

XXXX XX 3;

X335: X ≥ 25&xxxx;%

Xxx Xxxxx.2;

H319: X &xx; 25 %

&xxxx;

613-016-00-3

fuberidazole (XXX);

2-(2-xxxxx)-1X-xxxxxxxxxxxxx

223-404-0

3878-19-1

Xxxx. 2

Xxxxx Xxx. 4

STOT XX 2

Xxxx Xxxx. 1

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X351

X302

X373 (srdce)

X317

X400

X410

XXX07

GHS08

GHS09

Xxx

X351

X302

X373 (xxxxx)

X317

X410

&xxxx;

X = 1

&xxxx;

617-001-00-2

xx-xxxx-xxxxx xxxxxxxx

203-733-6

110-05-4

Xxx. Xxxxx. X

Xxxx. Xxx. 2

Muta. 2

H242

X225

X341

GHS02

XXX08

Xxx

X242

X225

X341&xxxxx;

&xxxx;

&xxxx;

&xxxx;

XŘ&Xxxxxx;XXXX&xxxx;XX

Xxxxxxx&xxxxxx; číslo

Xxxxx&xxxxxx;xxxx&xxxxxx; identifikace xxxxxxx&xxxxxx;xx látek

Č&xxxxxx;xxx XX

Číslo XXX

Xxxxxxxxxxx

Xxxxčxx&xxxxxx;

Xxxxxxxxx&xxxxxx; xxxxxxx. xxxxxx, xxxxxxxxxxčx&xxxxxx; xxxxxxx

Pozn.

X&xxxxxx;xx xř&xxxxxx;x x xxxxxxxx&xxxxxx; xxxxxxxčxxxxx

X&xxxxxx;xx xxxxxxxxx&xxxxxx;xx xěx x xxxxxxxčxxxxx

X&xxxxxx;xx výstražných xxxxxxů x xxxx&xxxxxx;xx&xxxxxx;xx xxxx

X&xxxxxx;xx xxxxxxxxx&xxxxxx;xx xěx x xxxxxxxčxxxxx

X&xxxxxx;xx xxxxň. xxxxxxxxx&xxxxxx;xx xěx x xxxxxxxčxxxxx

&xxxxx;015-199-00-X

xxxx[2-xxxxxx-1-xxxxxxxxxxxx)xxxxx] xxxxxxxxx

237-159-2

13674-87-8

Xxxx. 2

X351

XXX08

Xxx

X351

&xxxx;

 

 

015-200-00-3

xxxxxx xxxxxxxxx

244-959-5

22398-80-7

Carc. 1X

Xxxx. 2

XXXX XX 1

X350

X361x

X372 (xx&xxxxxx;xx)

XXX08

Dgr

X350

H361f

X372 (plíce)

 

STOT XX 1;

X372: C ≥ 0,1 %

Xxxx 1X;

X350: X&xxxx;&xx;&xxxx;0,01&xxxx;%

XXXX XX 2;

X373: 0,01&xxxx;%&xxxx;&xx; C < 0,1 %

 

015-201-00-9

trixylyl xxxxxxxxx

246-677-8

25155-23-1

Xxxx. 1X

X360X

XXX08

Dgr

H360F

&xxxx;

&xxxx;

 

015-202-00-4

xxxx(xxxxxxxxxxx) xxxxxxxxx

247-759-6

26523-78-4

Xxxx Xxxx. 1

Aquatic Acute 1

Xxxxxxx Chronic 1

X317

X400

X410

XXX07

XXX09

Wng

H317

H410

&xxxx;

&xxxx;

&xxxx;

015-203-00-X

xxxxxxxx(2,4,6-xxxxxxxxxxxxxxxx)xxxxxxxxx xxxxx

278-355-8

75980-60-8

Xxxx. 2

X361x (způsobuje xxxxxxx xxxxxx)

GHS08

Wng

H361f (způsobuje xxxxxxx xxxxxx)

 

 

&xxxx;

602-109-00-4

Xxxxxxxxxxxxxxxxxxxxxx [1]

247-148-4 [1]

25637-99-4[1]

Xxxx. 2

Xxxx.

H361

X362

XXX08

Xxx

H361

H362

 

&xxxx;

 

1,2,5,6,9,10-hexabromocyclododecane [2]

221-695-9[2]

3194-55-6[2]

606-143-00-0

abamectin (xxxxxxxxxxx xx avermectin X1x xxx xxxxxxxxxx X1x) (XXX) [1]

_ [1]

71751-41-2 [1]

Repr. 2

Acute Xxx. 2

Acute Tox. 1

XXXX RE 1

Xxxxxxx Xxxxx 1

Aquatic Xxxxxxx 1

X361x

X300

X330

X372 (xxxxxx&xxxxxx; xxxx&xxxxxx;x)

X400

X410

XXX06

GHS08

XXX09

Xxx

X361x

X300

H330

H372 (xxxxxx&xxxxxx; systém)

H410

&xxxx;

STOT RE 1;

X372: X&xxxx;&xx;&xxxx;5&xxxx;%

STOT XX 2;

X373: 0,5&xxxx;%&xxxx;&xx; X&xxxx;&xx;&xxxx;5&xxxx;%

X&xxxx;=&xxxx;10&xxxx;000

&xxxx;

xxxxxxxxxx X1x (xxxxxx &xx;&xxxx;80&xxxx;%); [2]

265-610-3 [2]

65195-55-3 [2]

606-144-00-6

xxxxxxxxxxx (XXX);

3-xxxxxxx-1,4-xxxxx-1,4-xxxxxxxxxxxxxxxxx-2-xx xxxxxxx

&xxxxx;

57960-19-7

Skin Xxxx. 1

XXXX XX 1

XXXX XX 2

Xxxxxxx Acute 1

Xxxxxxx Chronic 1

X317

H370 (xx&xxxxxx;xx)

(xxxxxxx&xxxxxx;x&xxxxxx;)

X373 (krevní xxěx)

X400

X410

XXX07

XXX08

XXX09

Xxx

X317

H370 (xx&xxxxxx;xx)

(xxxxxxx&xxxxxx;x&xxxxxx;)

X373 (xxxxx&xxxxxx; xxěx)

X410

&xxxx;

M = 1 000

&xxxx;

607-698-00-1

4-xxxx-xxxxxxxxxxxx xxxx

202-696-3

98-73-7

Xxxx. 1X

STOT RE 1

Xxxxx Tox. 4

H360F

X372

X302

XXX07

XXX08

Dgr

H360F

H372

H302

 

&xxxx;

&xxxx;

612-281-00-2

xxxxxxxxxxxxxx xxxxx;

X,X,X',X'-xxxxxxxxxxx-4,4'-xxxxxxxxxxxxxxxxxxxx

204-961-9

129-73-7

Xxxx. 2

Xxxx. 2

X351

X341

GHS08

Wng

X351

H341

 

 

&xxxx;

616-205-00-9

Xxxxxxxxxxx (XXX);

2-xxxxxx-X-(2,6-xxxxxxxxxxxxxx)-X-(1X-xxxxxxx-1-xxxxxxxx)xxxxxxxxx

266-583-0

67129-08-2

Xxxx Xxxx. 1X

Xxxx. 2

Xxxxxxx Acute 1

Xxxxxxx Xxxxxxx 1

H317

X351

H400

X410

XXX07

XXX08

XXX09

Xxx

X317

H351

H410

&xxxx;

X&xxxx;=&xxxx;100

M = 100“

 

XŘ&Xxxxxx;XXXX&xxxx;XXX

Xxxxxxx&xxxxxx; číslo

Xxxxx&xxxxxx;xxxx&xxxxxx; identifikace xxxxxxx&xxxxxx;xx x&xxxxxx;xxx

Číslo XX

Číslo XXX

Xxxxxxxxxxx

Xxxxčxx&xxxxxx;

Xxxxxxxxxčx&xxxxxx; xxxxxx

Xxxx.

„009-016-00-2

xxxxxxxxx hexafluoroaluminate [1]

237-410-6 [1]

13775-53-6 [1]

Xx; X20

X; R48/23/25

X; R51-53

T; X

X: 20-48/23/25-51/53

X: (1/2-)22-37-45-61

&xxxx;

&xxxx;

xxxxxxxxx xxxxxxxxxxxxxxxxxxx (cryolite) [2]

239-148-8 [2]

15096-52-3 [2]

603-012-00-X

2-xxxxxxxxxxxxx;

xxxxxxxx glycol xxxxxxxxx xxxxx

203-804-1

110-80-5

X10

Xxxx. Xxx. 2; X60-61

Xn; R20/22

X

X: 60-61-10-20/22

X: 53-45

 

X

603-025-00-0

xxxxxxxxxxxxxxx

203-726-8

109-99-9

F; X11-19

Xxxx. Xxx. 3; X40

Xi; X36/37

X; Xx

X: 11-19-40-36/37

S: (2-)(13-)16-29-33-36-37(-46)

Xx; X36/37: X&xxxx;&xx;&xxxx;25&xxxx;%

 

613-016-00-3

fuberidazole (XXX);

2-(2-xxxxx)-1X-xxxxxxxxxxxxx

223-404-0

3878-19-1

Xxxx. Cat. 3; X40

Xx; X48/22

Xx; X22

Xx; X43

X; X50-53

Xn; N

X: 40-48/22-22-43-50/53

X: (2)-22-36/37-60-61

X; X50-53: X&xxxx;&xx;&xxxx;25&xxxx;%

X; X51-53: 2,5&xxxx;%&xxxx;&xx;&xxxx;X&xxxx;&xx;&xxxx;25&xxxx;%

R52-53: 0,25&xxxx;%&xxxx;&xx;&xxxx;X&xxxx;&xx;&xxxx;2,5&xxxx;%

&xxxx;

617-001-00-2

xx-xxxx-xxxxx peroxide

203-733-6

110-05-4

X; R7

X; X11

Xxxx. Xxx. 3, X68

X; X; Xx

X: 7-11-68

X: (2-)3/7-14-16-23-36/37/39&xxxxx;

 

 

XŘ&Xxxxxx;XXXX&xxxx;XX

Xxxxxxx&xxxxxx; č&xxxxxx;xxx

Mezinárodní xxxxxxxxxxxx xxxxxxx&xxxxxx;xx x&xxxxxx;xxx

Č&xxxxxx;xxx ES

Číslo XXX

Xxxxxxxxxxx

Xxxxčxx&xxxxxx;

Xxxxxxxxxčx&xxxxxx; xxxxxx

Xxxx.

&xxxxx;015-199-00-X

xxxx[2-xxxxxx-1-xxxxxxxxxxxx)xxxxx] xxxxxxxxx

237-159-2

13674-87-8

Carc. Xxx. 3; X40

Xx

X: 40

X: (2-)36/37

&xxxx;

&xxxx;

015-200-00-3

xxxxxx phosphide

244-959-5

22398-80-7

Xxxx. Xxx. 2; X45

Xxxx. Xxx. 3; X62

X; X48/23

X

X: 45&xxxxx;48/23&xxxxx;62

S: 45- 53

X; R48/23: C &xx;0,1%

Xxxx Xxx 2; X45: X &xx; 0,01%

Xx; R48/20: 0,01%≤ X &xx; 0,1%

X

015-201-00-9

xxxxxxxx xxxxxxxxx

246-677-8

25155-23-1

Xxxx. Xxx. 2; X60

X

X: 60

X: 53-45

&xxxx;

 

015-202-00-4

xxxx(xxxxxxxxxxx) xxxxxxxxx

247-759-6

26523-78-4

Xx; X43

X; X50-53

Xx; X

X: 43-50/53

X: 24-37-60-61

&xxxx;

 

015-203-00-X

xxxxxxxx(2,4,6-xxxxxxxxxxxxxxxx)xxxxxxxxx xxxxx

278-355-8

75980-60-8

Xxxx. Xxx. 3; X62

Xx

X: 62

X: (2)-22-36/37.

&xxxx;

 

602-109-00-4

Xxxxxxxxxxxxxxxxxxxxxx [1]

247-148-4 [1]

25637-99-4[1]

Xxxx. Cat. 3; X63 R64

Xn

X: 63-64

X: 36/37-53

&xxxx;

&xxxx;

1,2,5,6,9,10-xxxxxxxxxxxxxxxxxxxxxx [2]

221-695-9[2]

3194-55-6[2]

606-143-00-0

abamectin (xxxxxxxxxxx xx xxxxxxxxxx B1a xxx avermectin B1b) (XXX) [1]

_ [1]

71751-41-2 [1]

Xxxx. Cat. 3; X63

X+; X26/28

X; R48/23/25

X; X50-53

X+; X

X: 63-26/28-48/23/25-50/53

X: 28-36/37-45-60-61

T; X48/23: X ≥ 5%

Xx; X48/20: 0,5% &xx; X &xx;5%

X; X50-53: C &xx; 0,0025%

X; X51-53: 0,00025% &xx; X &xx;0,0025%

X52-53: 0,000025% &xx; C<0,00025%

&xxxx;

xxxxxxxxxx X1x (xxxxxx &xx;80%); [2]

265-610-3 [2]

65195-55-3 [2]

606-144-00-6

xxxxxxxxxxx (XXX);

3-xxxxxxx-1,4-xxxxx-1,4-xxxxxxxxxxxxxxxxx-2-xx acetate

&xxxxx;

57960-19-7

X; R39/23

Xi; X43

X; R50-53

X; X

R: 39/23-43-50/53,

X: (2-)24-37-38-60-61

X; X50-53: X ≥ 0,025%

X; X51-53: 0,0025% ≤ X < 0,025%

X52-53: 0,00025% &xx; X &xx; 0,0025%

&xxxx;

607-698-00-1

4-xxxx-xxxxxxxxxxxx xxxx

202-696-3

98-73-7

Xxxx. Xxx. 2; X60

T; X48/23/24/25

Xx; R22

X

X: 60-22-48/23/24/25

X: 53-45

&xxxx;

X

612-281-00-2

xxxxxxxxxxxxxx xxxxx

X,X,X',X'-xxxxxxxxxxx-4,4'-xxxxxxxxxxxxxxxxxxxx

204-961-9

129-73-7

Xxxx. Xxx.&xxxx;3;X40

Muta. Xxx. 3; X68

Xx

R: 40-68

X: (2-)36/37

&xxxx;

&xxxx;

616-205-00-9

Xxxxxxxxxxx (ISO);

2-chloro-N-(2,6-dimethylphenyl)-N-(1H-pyrazol-1-ylmethyl)acetamide

266-583-0

67129-08-2

X43

Xxxx. Xxx. 3; X40

X; X50-53

Xx; X

X: 40-43-50/53

X: (2-)36-37-60-61

X; R50-53: C &xx; 0,25%

N; R51-53: 0,025% &xx; X &xx; 0,25%

X52-53: 0,0025% &xx; C < 0,025%&xxxxx;

&xxxx;